Published in AIDS Weekly, January 28th, 2002
Igor M. Belyakov and colleagues at the National Institutes of Health in Bethesda, Maryland, the Wisconsin Regional Primate Center in Madison, Wisconsin, the Emory University Vaccine Center in Atlanta, Tulane University in New Orleans, Epimmune, Inc., in San Diego, and Advanced BioScience Laboratories, Inc., in Kensington, Maryland, evaluated the effect of delivery route on the efficacy of HIV vaccines.
They found that mucosal administration enhanced the potency of vaccine-induced antiviral...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.